Correct administration time and dosage guide for Opicapone
The standard recommended dose of Opicapone is 50 mg once daily, with no adjustment based on weight or age. The correct medication time is to take it every day before going to bed in the evening on an empty stomach. It is best to separate it from dopamine drugs such as levodopa/carbidopa for at least 1 hour to avoid drug absorption or metabolic interactions. Taking it on an empty stomach can help improve drug bioavailability, as food, especially a high-fat diet, may slightly affect how efficiently Opicapone is absorbed.
Clinically, it is emphasized that opicapone should be used as part of a combination of levodopa and cannot be used alone. Its function is to prolong and strengthen the effect of levodopa. There is no need to adjust the existing levodopa dose when using Opicapone for the first time, but the doctor will further fine-tune the levodopa dose based on the patient's response to the prolonged drug effect to avoid dopamine overdose reactions, such as dyskinesias or hallucinations.
Opicapone treatment should be continued for a long time. It is not recommended to interrupt or suddenly stop the treatment, unless under the guidance of a professional physician, because sudden withdrawal may cause the "switch" phenomenon to reappear or worsen Parkinson's symptoms. In addition, patients with severe hepatic impairment should use this drug with caution or avoid using it because it is mainly metabolized in the liver. In elderly patients, the safety and tolerability data of opicapone are good, but changes in levodopa-related side effects also need to be closely observed.
In general, Opicapone can be taken once a day on an empty stomach in a simple way. It has a stable effect and is well tolerated. It has become a key part of the drug combination for patients with advanced Parkinson's disease. In order to obtain the best effect, patients should follow the doctor's prescription, take medication regularly every day, and have regular follow-up visits to monitor changes in their condition.
Reference materials:https://www.ongentys.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)